• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    10/13/23 1:14:35 PM ET
    $AG
    $AMC
    $BDC
    $BLPH
    Precious Metals
    Basic Materials
    Movies/Entertainment
    Consumer Discretionary
    Get the next $AG alert in real time by email

    Gainers

    • Sigma Additive Solutions, Inc. (NASDAQ:SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares climbed 102% to $0.7961 after gaining more than 6% on Thursday.
    • Shift Technologies, Inc. (NASDAQ:SFT) gained 60% to $0.2145, after falling around 21% on Thursday.
    • C3is Inc. (NASDAQ:CISS) gained 32% to $0.5625.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results.
    • Versus Systems Inc. (NASDAQ:VS) shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday.
    • Outlook Therapeutics, Inc. (NASDAQ:OTLK) gained 26% to $0.3448
    • SunOpta Inc. (NASDAQ:STKL) gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature's Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results.
    • PSQ Holdings, Inc. (NYSE:PSQH) climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth.
    • EHang Holdings Limited (NASDAQ:EH) jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China.
    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia.
    • Celularity Inc. (NASDAQ:CELU) rose 17.7% to $0.3179.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) gained 16% to $0.3826.
    • Hecla Mining Company (NYSE:HL) climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4.
    • Viasat, Inc. (NASDAQ:VSAT) climbed 13.5% to $19.06.
    • Coeur Mining, Inc. (NYSE:CDE) gained 13.2% to $2.5399.
    • Groupon, Inc. (NASDAQ:GRPN) jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target.
    • Synchronoss Technologies, Inc. (NASDAQ:SNCR) surged 13% to $0.5426.
    • Oblong, Inc. (NASDAQ:OBLG) shares gained 12.1% to $0.3286.
    • Blue Star Foods Corp. (NASDAQ:BSFC) shares gained 10% to $0.2201.
    • Staffing 360 Solutions, Inc. (NASDAQ:STAF) rose 9.2% to $0.7550.
    • Dollar General Corporation (NYSE:DG) climbed 8.5% to $110.50 after the company updated financial guidance for FY23 and announced Todd Vasos has been appointed CEO.
    • First Majestic Silver Corp. (NYSE:AG) climbed 8.5% to $5.34.
    • The Progressive Corporation (NYSE:PGR) gained 7.7% to $154.27 after the company reported third-quarter results.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 6.9% to $0.3976. RedHill Biopharma recently said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S. Army-funded in vivo Ebola virus study, making it the first host-directed molecule to show activity in the Ebola virus disease.
    • JPMorgan Chase & Co. (NYSE:JPM) gained 3.6% to $151.09 as the company reported better-than-expected earnings for its third quarter on Friday.
    • Wells Fargo & Company (NYSE:WFC) gained 3.2% to $41.03 following third-quarter earnings.

    Losers

    • Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) fell 53.4% to $0.1852.
    • Outset Medical, Inc. (NASDAQ:OM) shares fell 47.6% to $3.55. The company announced preliminary revenue for the third quarter of $30.4 million, below the consensus estimate of $36.03 million.
    • MSP Recovery, Inc. (NASDAQ:LIFW) dipped 44% to $1.8109.
    • SMART Global Holdings, Inc. (NASDAQ:SGH) fell 40.4% to $14.04 after the company reported worse-than-expected fourth-quarter financial results and issued a weak forecast for the first quarter.
    • Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) declined 38.3% to $18.66 after the company reported topline data from its Phase 3 INTUNE study of pitolisant for IH, noting no statistically significant difference was observed
    • between pitolisant and placebo on ESS.
    • Secoo Holding Limited (NASDAQ:SECO) fell 38% to $0.6327.
    • FLJ Group Limited (NASDAQ:FLJ) fell 31.9% to $0.2301.
    • PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) declined 27.7% to $1.7999. PMV Pharmaceuticals recently announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a favorable safety profile.
    • LQR House Inc. (NASDAQ:LQR) declined 26.6% to $0.1739 after the company announced the pricing of a $5.4 million public offering of 28,421,053 shares of common stock at a price of $0.19 per share.
    • Belden Inc. (NYSE:BDC) fell 25.7% to $70.76 after the company lowered third-quarter revenue guidance below estimates.
    • Scully Royalty Ltd. (NYSE:SRL) declined 25% to $4.1990.
    • Charles & Colvard, Ltd. (NASDAQ:CTHR) fell 23% to $0.44 following quarterly results.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) fell 21.3% to $13.80 after a recent report by the City University of New York implicated a long-time collaborator of the company in scientific misconduct related to 20 research papers.
    • Edesa Biotech, Inc. (NASDAQ:EDSA) shares fell 21.1% to $3.8501 after jumping around 80% on Thursday. Edesa Biotech secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
    • Prestige Wealth Inc. (NASDAQ:PWM) fell 18.7% to $3.43.
    • ReShape Lifesciences Inc. (NASDAQ:RSLS) fell 17.9% to $0.2795, after surging over 25% on Thursday.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 17.8% to $0.8301. Nuwellis reported pricing of $2.25 million public offering of Series J convertible redeemable preferred stock and warrants.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 15.7% to $0.8850, after jumping 28% on Thursday.
    • BeyondSpring Inc. (NASDAQ:BYSI) shares fell 15.1% to $0.9089, after jumping 46% on Thursday.
    • ATRenew Inc. (NYSE:RERE) declined 13.4% to $1.8350.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) fell 11.5% to $6.90.
    • Sterling Infrastructure, Inc. (NASDAQ:STRL) fell 11.2% to $68.79.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 9.9% to $9.91.
    • LogicMark, Inc. (NASDAQ:LGMK) shares fell 9.7% to $1.76 after jumping around 25% on Thursday.
    • Society Pass Incorporated (NASDAQ:SOPA) shares fell 9.7% to $0.3201. Society Pass shares jumped around 33% on Thursday after the company announced an equity line of up to $40 million to invest into operating subsidiaries projected to go public in 2024.
    • Ribbon Communications Inc. (NASDAQ:RBBN) declined 8.8% to $2.2050.
    • Hormel Foods Corporation (NYSE:HRL) fell 4.5% to $30.93 following the company's Thursday investor day event. Additionally, Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $33 to $29.
    • JD.com, Inc. (NASDAQ:JD) fell 4.1% to $26.71. Macquarie downgraded JD.com from Outperform to Neutral and lowered the price target from $52 to $32, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight and slashed the price target from $55 to $33.

    Now Read This: Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things'

    Get the next $AG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AG
    $AMC
    $BDC
    $BLPH

    CompanyDatePrice TargetRatingAnalyst
    Tango Therapeutics Inc.
    $TNGX
    2/23/2026$19.00Outperform
    Mizuho
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/23/2026Buy → Hold
    Deutsche Bank
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/23/2026Buy → Hold
    Truist
    Coeur Mining Inc.
    $CDE
    2/20/2026Buy → Hold
    Canaccord Genuity
    Dollar General Corporation
    $DG
    2/17/2026$111.00Neutral → Sell
    Rothschild & Co Redburn
    Wells Fargo & Company
    $WFC
    2/13/2026$85.00Underperform → Neutral
    Robert W. Baird
    Sterling Infrastructure Inc.
    $STRL
    2/12/2026$486.00Buy
    Stifel
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/11/2026$46.00Neutral
    UBS
    More analyst ratings

    $AG
    $AMC
    $BDC
    $BLPH
    SEC Filings

    View All

    SEC Form 6-K filed by First Majestic Silver Corp.

    6-K - FIRST MAJESTIC SILVER CORP (0001308648) (Filer)

    3/10/26 5:26:25 PM ET
    $AG
    Precious Metals
    Basic Materials

    Outlook Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Outlook Therapeutics, Inc. (0001649989) (Filer)

    3/10/26 4:30:54 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Groupon Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Groupon, Inc. (0001490281) (Filer)

    3/10/26 4:15:19 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $AG
    $AMC
    $BDC
    $BLPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Nijhawan Pardeep bought $6,599 worth of shares (1,000 units at $6.60), increasing direct ownership by 0.16% to 628,813 units (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/10/26 5:02:16 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nijhawan Pardeep bought $39,000 worth of shares (10,000 units at $3.90) (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/6/26 5:01:15 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nijhawan Pardeep bought $42,560 worth of shares (10,000 units at $4.26) (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/5/26 5:01:11 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $AMC
    $BDC
    $BLPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Tango Therapeutics with a new price target

    Mizuho initiated coverage of Tango Therapeutics with a rating of Outperform and set a new price target of $19.00

    2/23/26 8:40:01 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Harmony Biosciences downgraded by Deutsche Bank

    Deutsche Bank downgraded Harmony Biosciences from Buy to Hold

    2/23/26 8:31:47 AM ET
    $HRMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Harmony Biosciences downgraded by Truist

    Truist downgraded Harmony Biosciences from Buy to Hold

    2/23/26 8:31:36 AM ET
    $HRMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $AMC
    $BDC
    $BLPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Nijhawan Pardeep bought $6,599 worth of shares (1,000 units at $6.60), increasing direct ownership by 0.16% to 628,813 units (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/10/26 5:02:16 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sr. Executive Vice President Van Beurden Saul converted options into 88,176 shares and covered exercise/tax liability with 45,014 shares, increasing direct ownership by 20% to 259,269 units (SEC Form 4)

    4 - WELLS FARGO & COMPANY/MN (0000072971) (Issuer)

    3/9/26 4:53:13 PM ET
    $WFC
    Major Banks
    Finance

    Sr. Executive Vice President Sommers Barry converted options into 101,035 shares and covered exercise/tax liability with 50,699 shares, increasing direct ownership by 27% to 235,242 units (SEC Form 4)

    4 - WELLS FARGO & COMPANY/MN (0000072971) (Issuer)

    3/9/26 4:51:28 PM ET
    $WFC
    Major Banks
    Finance

    $AG
    $AMC
    $BDC
    $BLPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    First Majestic Announces Results of the 2025 Drilling Program at Jerritt Canyon Gold Mine

    Exploration drilling results underscore the potential for further Mineral Resource expansionVancouver, British Columbia--(Newsfile Corp. - March 10, 2026) - First Majestic Silver Corp. (NYSE:AG) (TSX:AG) (FSE: FMV) (the "Company" or "First Majestic") is pleased to announce the results of a successful 2025 exploration program at its Jerritt Canyon Gold Mine ("Jerritt Canyon") located in Nevada, USA, including the Mahala, Javelin, and Saval targets within the Smith-SSX-Saval mining area. The Company believes these results underscore the potential for expanding gold Mineral Resources at Jerritt Canyon to include both open-pit and underground resources."The success of our 2025 drilling program a

    3/10/26 5:09:00 PM ET
    $AG
    Precious Metals
    Basic Materials

    Groupon Launches Board-Level Artificial Intelligence Committee and Appoints Amit Shah to Board of Directors

    Technology executive and AI entrepreneur to chair new committee as Company positions marketplace for the era of agentic commerceChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced the appointment of Amit Shah to its Board of Directors, effective March 10, 2026, and the formation of a dedicated Artificial Intelligence Committee of the Board. Shah, a seasoned technology executive and AI entrepreneur, will serve as the Committee's inaugural Chair.With this action, Groupon becomes one of the first publicly traded consumer marketplaces to establish a board-level committee dedicated to artificial intelligence. The formation of the Committee reflects t

    3/10/26 4:15:00 PM ET
    $APRN
    $FLWS
    $GRPN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores
    Advertising

    Groupon Reports Fourth Quarter and Fiscal Year 2025 Results

    North America Q4 Local Revenue +4% and Local Billings +9%North America 2025 Local Revenue +5% and Local Billings +14%Positive Trailing twelve month operating cash flow from continuing operations of $64.5 million and Free Cash Flow of $49.9 millionChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the quarter and year ended December 31, 2025 and provided details on its recent operating progress. The Company filed its Form 10-K with the Securities and Exchange Commission and posted earnings commentary including an updated presentation on its investor relations website (investor.groupon.com)."Our 2025 results represent a

    3/10/26 4:15:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $AG
    $AMC
    $BDC
    $BLPH
    Leadership Updates

    Live Leadership Updates

    View All

    Groupon Launches Board-Level Artificial Intelligence Committee and Appoints Amit Shah to Board of Directors

    Technology executive and AI entrepreneur to chair new committee as Company positions marketplace for the era of agentic commerceChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced the appointment of Amit Shah to its Board of Directors, effective March 10, 2026, and the formation of a dedicated Artificial Intelligence Committee of the Board. Shah, a seasoned technology executive and AI entrepreneur, will serve as the Committee's inaugural Chair.With this action, Groupon becomes one of the first publicly traded consumer marketplaces to establish a board-level committee dedicated to artificial intelligence. The formation of the Committee reflects t

    3/10/26 4:15:00 PM ET
    $APRN
    $FLWS
    $GRPN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores
    Advertising

    NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

    Transaction expected to approximately triple NEXGEL's annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified suite of 6 established regenerative biomaterial products, most with existing insurance reimbursement, along with three new product 510(k) filings planned for 2026, 2027, and 2028 Experienced commercial team is expected to join NEXGEL, significantly expanding the Company's sales reach and operational capabilities LANGHORNE, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of healthcare, beauty, and over-the-counter (OTC) pr

    3/10/26 8:45:00 AM ET
    $CELU
    $NXGL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    ATRenew Inc. Announces Appointment of New Director

    SHANGHAI, March 6, 2026 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE:RERE), a pioneer in technology-driven recycling and trade-in solutions for consumer products in China, today announced that Mr. Yue Teng has been appointed as a new member of the Company's board of directors (the "Board") and the compensation committee of the Board, and Ms. Rui Zhu has been appointed as a new member of the nominating and corporate governance committee of the Board, effective immediately, to fill the vacancies arising from the resignation of Mr. Mervin Ye Zhou. Upon the appointment of Mr. Yue Teng, the Board consists of eight members: Mr. Kerry Xuefeng Chen, Mr. Yongliang Wang, Mr. Chen Ch

    3/6/26 3:00:00 AM ET
    $RERE
    Other Specialty Stores
    Consumer Discretionary

    $AG
    $AMC
    $BDC
    $BLPH
    Financials

    Live finance-specific insights

    View All

    Groupon Reports Fourth Quarter and Fiscal Year 2025 Results

    North America Q4 Local Revenue +4% and Local Billings +9%North America 2025 Local Revenue +5% and Local Billings +14%Positive Trailing twelve month operating cash flow from continuing operations of $64.5 million and Free Cash Flow of $49.9 millionChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the quarter and year ended December 31, 2025 and provided details on its recent operating progress. The Company filed its Form 10-K with the Securities and Exchange Commission and posted earnings commentary including an updated presentation on its investor relations website (investor.groupon.com)."Our 2025 results represent a

    3/10/26 4:15:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights: Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially.208% increase in U.S. console sales in Q4 versus prior year quarter.Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4.Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter.Closed a $5.0 million private p

    3/10/26 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Progressive Announces Quarterly Common Share Dividend

    MAYFIELD VILLAGE, OHIO, March 09, 2026 (GLOBE NEWSWIRE) -- On March 6, 2026, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared a $0.10 per common share dividend, payable April 10, 2026, to shareholders of record at the close of business on April 2, 2026. About ProgressiveProgressive Insurance® makes it easy to understand, buy and use car insurance, home insurance, and other protection needs. Progressive offers choices so consumers can reach us however it's most convenient for them — online at progressive.com, by phone at 1-800-PROGRESSIVE, via the Progressive mobile app, or in-person with a local agent. Progressive provides insurance for personal and commercial au

    3/9/26 10:47:35 AM ET
    $PGR
    Property-Casualty Insurers
    Finance

    $AG
    $AMC
    $BDC
    $BLPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Prestige Wealth Inc.

    SC 13G/A - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:04 PM ET
    $PWM
    Finance: Consumer Services
    Finance